Crescent Pharma recognises the vital role our medicines play in the healthcare system and the responsibility that comes with supplying patients across the UK. We are committed to ensuring healthcare professionals have reliable access to high-quality medicines, helping patients receive the treatments they need, when they need them.
Every year, Crescent Pharma supplies over 250 million packs and more than 7 billion tablets and capsules to the UK market through one of the country’s largest independent generic medicine portfolios. Supported by over 127 NHS hospital contract lines, we supply more than 11 million packs annually to the NHS, while also serving retail pharmacies, wholesalers and international markets.
Quality is at the heart of everything we do. Our UK manufacturing, testing, certification and batch release processes operate to the highest Good Manufacturing Practice (GMP) and regulatory standards, supported by extensive UK distribution infrastructure and long-term supply partnerships. This integrated approach enables Crescent Pharma to deliver a resilient, dependable supply of high-quality generic medicines that healthcare professionals and patients can trust.
Over 250 million
packs delivered
to the UK market
Crescent Pharma is committed to maintaining a resilient, agile and efficient supply chain that ensures the continuous availability of high-quality medicines for our customers, healthcare providers and the patients who rely on them.
Crescent Pharma works in close partnership with a carefully selected network of approved manufacturing and supply partners to deliver safe, high-quality medicines through a secure and resilient UK and global supply chain.